Acadia Healthcare (NASDAQ:ACHC) Earns Buy Rating from Analysts at Guggenheim

Guggenheim started coverage on shares of Acadia Healthcare (NASDAQ:ACHC - Free Report) in a report released on Wednesday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $36.00 price objective on the stock.

A number of other research analysts also recently weighed in on the company. Barclays downgraded Acadia Healthcare from an "overweight" rating to an "equal weight" rating and reduced their target price for the stock from $43.00 to $35.00 in a report on Friday, February 28th. Mizuho decreased their price objective on Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating for the company in a report on Tuesday, March 25th. Bank of America dropped their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a report on Friday, February 28th. TD Cowen decreased their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research note on Tuesday, January 7th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $50.39.

Remove Ads

Acadia Healthcare Trading Down 0.5 %

Shares of ACHC traded down $0.13 during trading hours on Wednesday, reaching $26.02. 441,349 shares of the company traded hands, compared to its average volume of 1,470,883. Acadia Healthcare has a 12 month low of $25.41 and a 12 month high of $82.41. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The company's fifty day moving average price is $33.22 and its two-hundred day moving average price is $40.94. The company has a market capitalization of $2.42 billion, a price-to-earnings ratio of 8.53, a price-to-earnings-growth ratio of 1.46 and a beta of 1.13.

Hedge Funds Weigh In On Acadia Healthcare

A number of hedge funds have recently added to or reduced their stakes in ACHC. State Street Corp increased its holdings in shares of Acadia Healthcare by 3.5% in the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company's stock worth $178,811,000 after purchasing an additional 95,613 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock worth $198,258,000 after buying an additional 454,044 shares in the last quarter. SG Americas Securities LLC raised its position in Acadia Healthcare by 713.3% in the 4th quarter. SG Americas Securities LLC now owns 110,866 shares of the company's stock worth $4,396,000 after buying an additional 97,235 shares during the last quarter. Beach Point Capital Management LP bought a new position in Acadia Healthcare during the 4th quarter valued at about $14,097,000. Finally, Geode Capital Management LLC boosted its holdings in shares of Acadia Healthcare by 0.9% during the 3rd quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company's stock valued at $102,320,000 after acquiring an additional 14,197 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.